Skip to main content
Premium Trial:

Request an Annual Quote

Page Leaving 23andMe

Andy Page, the president of 23andMe, is leaving his position, Recode reports. It adds that he is to remain on the firm's board of directors.

Page joined 23andMe's board in 2012, when he was president of Gilt Group, and he became 23andMe's president, which was a new position, the following year. As president, Page oversaw the firm's product and engineering, marketing, finance, business development, laboratory operations, and legal and regulatory affairs, as GenomeWeb reported at the time. This enabled 23andMe CEO and co-founder Anne Wojcicki to concentrate on the firm's research and management activities.

Recode notes that shortly after Page's arrival, 23andMe had regulatory issues to grapple with, as the US Food and Drug Administration sent the firm a warning letter in November 2013. The company had to halt its sales of its health testing kit, and it has begun to sell its kit again in a different form.

Now Recode reports that, in a letter to employees, Wojcicki wrote that "Andy and I recognize 23andMe is at a stage of strength and maturity where it would benefit from one single leader. Moving forward, Andy's direct reports will report to me."

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.